These candidate genes included FCRL5, adenosine monophosphate deaminase 1 (AMPD1), CCL18, tumor-necrosis factor receptor superfamily 17 (TNFRSF17) and leukocyte immunoglobin-like receptor, subfamily A (without TM domain) member 3 (LILRA3), and IRF4 which has shown to be involved in chronic inflammatory diseases such as RA and inflammatory bowel disease (IBD), (Table 5). This evidence concerns the gene FCRL5 and rheumatoid arthritis.